TransPerfect Life Sciences, a leading provider of content solutions and technologies to support global clinical trials and product development for the biopharmaceutical industry, announced that the AO Foundation selected its award-winning Trial Interactive platform, including eISF, Study Collaborate, and eTMF, to support the foundation’s upcoming clinical trials.
Based in Davos, Switzerland, the AO Foundation is a not-for-profit organization that focuses on improving the treatment of musculoskeletal disorders and trauma. By integrating Trial Interactive’s eClinical solutions, the AO Foundation is taking a significant step toward supporting its project managers and data scientists with a fully digital and inspection-ready infrastructure.
Health Technology Insights: Roche Invests $550 Million to Expand Indianapolis Diagnostics Hub
“Our collaboration with the AO Foundation reflects a shared commitment to advancing healthcare through innovation,” commented Michael Smyth, Division President of Trial Interactive. “By transitioning from legacy systems and paper-based processes to our robust and interoperable eClinical platform, the AO Foundation is well-positioned to achieve operational excellence and regulatory compliance.”
Health Technology Insights: PRISM MarketView Spotlights Emerging Innovators for Mental Health Awareness Month
“Trial Interactive’s expertise is an excellent match to our engagement in clinical trials,” remarked Dr. Katrin Simioni, Deputy Head of Clinical Operations at the AO Foundation. “Their platforms offer all features we need to improve our workflows, ensuring high-quality studies for our mission to improve patient treatment.”
Health Technology Insights: PharmaSentinel Secures License Agreement with Pay10 for Medsii.com
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
